Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2016

View Archived Issues

EMA committee hands down positive opinion on Arzerra for relapsed CLL

Eagle Pharmaceuticals to acquire Arsia Therapeutics

European approval for Parsabiv to treat secondary hyperparathyroidism in hemodialysis patients

Combining Cas9 RNP with ssODN mediates efficient HSPC genome editing of sickle mutation

Eagle Pharmaceuticals initiates rolling NDA for Ryanodex in EHS

EMA adopts positive opinion for Novo Nordisk's Fiasp

EMA gives positive opinion on Gilead's MAA for Vemlidy

Ultragenyx Pharmaceutical withdraws conditional MAA from the EMA for Ace-ER

Recent Esteve patent describes sigma1 receptor ligands for pain

Harvard College reports insulin-degrading enzyme inhibitors

Constellation Pharmaceuticals prepares and tests LSD1 inhibitors

The Vanderbilt University discloses M1 receptor PAMs

Medshine Discovery presents JAK2 inhibitors

Interim phase I/II data presented on combination of lirilumab and nivolumab in head & neck cancer

Novel nanomedicine with alendronic acid corona shows promise for treatment of osteosarcoma

EMA's CHMP recommends approval of Suliqua

European Commission approves use of ustekinumab for Crohn's disease

Promising phase III topline results for CAM-2038 to treat moderate to severe opioid use disorder

Immune activation seen with CD122-biased cytokine NKTR-214 in cancer patients

OncBioMune updates progress in acquisition of Vitel Laboratorios

Blockade of H1R and H4R has additive effects in suppressing peanut-induced intestinal anaphylaxis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...